Tag: Ankylosing Spondylitis
FDA Approves Bimzelx for Three New Indications
New indications include active psoriatic arthritis, nonradiographic axial spondyloarthritis with objective signs of inflammation, and ankylosing spondylitis
Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA
TNFi recommended over secukinumab, ixekizumab for AS and nonradiographic axial SpA as first biologic
Secukinumab Cuts Symptoms of Ankylosing Spondylitis
Two trials show benefits for 150 mg subcutaneous secukinumab with IV, subcutaneous loading
Restless Leg Syndrome Common in Ankylosing Spondylitis
Peripheral arthritis, uveitis, anemia, smoking, polyneuropathy higher in AS patients with RLS
